Articles

SOT 2013 Annual Meeting and ToxExpo: One-stop toxicology shop (Part 1)

Annual meeting of the Society of Toxicology promises a wide range of toxicology and safety assessment science
Written byJeffrey Bouley
| 5 min read

SAN ANTONIO, Texas—According to the Society of Toxicology(SOT), its annual meeting is the largest gathering of its type. So, it onlymakes sense for the biggest thing in toxicology to take place in a state knownfor things being grandiose and often physically large—Texas. Specifically, themeeting will take place in San Antonio, home of the Alamo, at the Henry B.Gonzalez Convention Center from March 10-14.

"We're excited about this meeting because it is the biggestof its kind in the world," says Dr. William Slikker Jr., 2012-13 president ofthe SOT and the director of the U.S. Food and Drug Administration's NationalCenter for Toxicological Research. "It's an event that draws attendance fromall across the United States, but more than that, about 20 percent of attendeesattend from places outside the U.S., as far away as Australia, China, LatinAmerica and Africa. We truly appreciate the opportunity each year to share thelatest science of toxicology literally to the whole world."

Based on past attendance, some 7,300 or more people frommore than 50 nations will attend SOT's show for the scientific program, ToxExpoand the various social and networking events. Slikker says there are already2,500 abstracts, so "the entire science of toxicology will be on display andcovered at the meeting."

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue